Select Page

Moderna plans to spend about $500 million to build a state-of-the-art mRNA facility in Africa. At present, only about 4.5% of Africans had been fully vaccinated against COVID-19, according to the continent’s top public health official. The proposed site is likely to include drug substance manufacturing as well as bottling and packaging capabilities.

Read the original article here: